Resultados: 7

    Diagnosis and management of heparin-induced thrombocytopenia: third edition

    Br. j. haematol; 204 (2), 2024
    This guideline updates and widens the scope of the previ-ous British Society for Haematology (BSH) Clinical guide-lines for Diagnosis and Management of Heparin-Induced Thrombocytopenia: Second Edition1 to include functional assays in the diagnosis of heparin-induced thrombocy...

    Guideline for the diagnosis and management of marginal zone lymphomas: a British Society of Haematology guideline

    Br. j. haematol; 204 (1), 2024
    The objective of this guideline is to provide healthcare professionals with clear guidance on the diagnosis and management of patients with marginal zone lymphoma (MZL)....

    Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology guideline

    Br. j. haematol; 204 (1), 2024
    This document represents an update of the British Society for Haematology (BSH) guideline on myelofibrosis (MF) first published in 2012 and updated in 2015.1 This guideline aims to provide healthcare professionals with clear guidance on the diagnosis and prognostic evaluation of primary m...

    The management of myelofibrosis: a British Society for Haematology guideline

    Br. j. haematol; 204 (1), 2024
    This document represents an update of the British Society for Haematology guideline on Myelofibrosis first published in 2012 and updated in 2015 These guidelines aim to pro-vide healthcare professionals with clear guidance on stratified management for primary myelofibrosis (PMF)...

    A British Society for haematology guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies

    Br. j. haematol; 203 (4), 2023
    The objective of this guideline is to provide healthcare professionals with clear, up-to-date and practical guidance on the management of thrombotic thrombocytopenic purpura (TTP) and related thrombotic microangiopathies (TMAs), including complement-mediated haemolytic uraemic syndrome (CM HUS); these ar...

    Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B

    Br. j. haematol; 190 (), 2020
    The writing group produced the draft guideline, which was subsequently revised by consensus. Review of the manuscript was performed by the BSH Guidelines Committee Haemostasis and Thrombosis Taskforce, the BSH Guidelines Committee and the Haemostasis and Thrombosis sounding board of the BSH. It was also ...

    Guideline on aspects of cancer-related venous thrombosis

    Br. j. haematol; 170 (5), 2015
    The guideline was drafted by a writing group identified by the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology (BCSH). All the authors are consultants in haematology in the UK. A search was performed of PubMed and Embase using the term 'cancer' combined with 't...